Psyence Biomedical PBM
NASDAQ PBM
$4.16 +0.05 (+1.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

Psyence Biomedical (PBM) EBITDA Margin (2025)

Updated

Analysis

Psyence Biomedical (PBM) EBITDA Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 32.68%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 49.01%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.02%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 33.11%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 39.16%
10 Psyence Biomedical 2.26 Mn -20.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,142.24%
API Access

Psyence Biomedical EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PBM&period=max&api_key=YOUR_API_KEY